- In November 2023, Siemens Healthineers introduced the ACUSON Maple ultrasound system, a versatile and cost-effective solution designed for high-volume clinical settings. Equipped with AI-powered applications, it enhances diagnostic efficiency and supports a broad range of imaging needs. The system's lightweight, portable design and up to 75 minutes of battery-powered scanning make it ideal for emerging markets and smaller healthcare centers. With support for 15 transducers and 25 advanced features, the ACUSON Maple streamlines workflow and improves usability. Its AI tools, such as Auto OB and eSie Measure, automate tasks, reducing measurement time and keystrokes, thereby increasing overall exam efficiency. This development positions Siemens Healthineers to better serve diverse clinical environments, particularly in regions with power supply challenges and limited resources
- In March 2023, the District Hospital in Baloda Bazar, Raipur, India, inaugurated a modern physiotherapy unit equipped with advanced therapeutic devices. The government-installed equipment includes TENS machines, IFT muscle stimulators, traction machines, shortwave diathermy (SWD), ultrasound therapy units, static bicycles, and Cordysafe chairs. These additions aim to provide comprehensive physiotherapy services for conditions such as arthritis, sciatica, post-operative limb stiffness, and neurological disorders in children. The upgraded facility enhances treatment accessibility and quality for patients in Raipur and surrounding areas, addressing a critical gap in rehabilitation services
- In January 2023, the Association of British HealthTech Industries (ABHI) and the UK Government Pavilion at Arab Health 2023 marked their most successful year to date. The event attracted a record 135,880 professionals from 183 countries and featured 3,358 exhibitors, solidifying its position as the premier platform for the global healthcare community in the Middle East. The UK Pavilion, the second largest at the event, showcased the strengths of UK healthcare innovation and celebrated collaborations between healthcare providers, clinicians, NHS Trusts, and healthcare technology companies. Over 80% of exhibitors rebooked on the spot for the 2024 exhibition, with a waiting list now in place for UK companies wishing to participate
- In February 2022, DJO, LLC, a leading global provider of medical technologies, renewed its partnership with the Professional Football Athletic Trainers Society (PFATS). This longstanding collaboration, which began in 2008, focuses on enhancing athlete safety, performance, and innovation in professional football. As part of the renewed partnership, PFATS will continue to recommend and endorse specific DJO products, including bracing and rehabilitation devices, to its members. In addition, PFATS members will serve as a sounding board for new and existing DJO devices and therapies, providing valuable feedback to drive product development. This partnership aims to promote athlete health and wellness through programs such as DJO’s preventive bracing initiative, "Join the Club," which focuses on injury prevention for high school athletes. By collaborating on evidence-based research and offering top-quality products, DJO and PFATS are committed to safeguarding athletes' health and pushing the limits of athletic performance
- In January 2022, BTL Industries (UK) expanded its physiotherapy product portfolio by integrating robotic rehabilitation devices, including the PerPedes gait training robot from Schepp MedTech. This strategic move enhances BTL's offerings in robotic rehabilitation, aligning with the growing demand for advanced therapeutic technologies. The incorporation of these devices aims to improve patient outcomes by providing precise and personalized rehabilitation therapies. This development positions BTL to better serve healthcare providers seeking innovative solutions for patient recovery and rehabilitation
- In January 2022, Zynex, Inc. (NASDAQ: ZYXI), a U.S.-based medical technology company, expanded its pain management portfolio by introducing post-operative and osteoarthritis (OA) knee braces. This strategic move aims to address the high incidence of knee injuries and OA, which are leading causes of orthopedic consultations. The new knee braces are designed to alleviate pain, enhance mobility, and potentially delay the need for surgical interventions by reducing joint wear and tear. Zynex's nationwide sales force is being trained to promote these products, which are well-recognized among orthopedic prescribers and commonly reimbursed by health insurance companies. This addition diversifies Zynex's revenue streams and strengthens its position in the orthopedic market
